Personalized DBS Targeting for Treating Depression
NCT: NCT06784388 · RECRUITING
Brief Summary
The goal of this clinical trial is to optimize the target brain areas for deep brain stimulation (DBS) for depression based on personalized brain imaging and stereo-electroencephalography（SEEG), to administer long-term DBS treatment in the target brain areas, to assess the effectiveness and safety of DBS for refractory depression and to validate the method of personalized optimization of DBS targets. The main questions it aims to answer are: 1. Where is the optimal DBS target brain region for each patient? 2. What are the optimal DBS parameters for each patient ? 3. What are the neural biomarkers of depression symptoms for each patient? 4. Are the optimized DBS strategies effective in treating refractory depression?
Frequently Asked Questions
What is Personalized DBS Targeting for Treating Depression?
Personalized DBS Targeting for Treating Depression is a clinical trial registered under NCT06784388. Current status: RECRUITING.
What is the status of NCT06784388?
The current status of NCT06784388 (Personalized DBS Targeting for Treating Depression) is: RECRUITING.
When did Personalized DBS Targeting for Treating Depression start?
Personalized DBS Targeting for Treating Depression started on 2025-01-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.